Mass General Brigham partners with AvoMD to enhance rapid response care workflows, integrating digital tools into clinical processes via EHR and mobile apps. AvoMD’s solutions aid in identifying at-risk patients and offering real-time guidance. The collaboration aims to mitigate clinician burnout and improve care quality. AvoMD’s recent funding indicates the growing trend of AI-driven solutions in healthcare for streamlined workflows and enhanced patient care.
Mass General Brigham has partnered with AvoMD to enhance rapid response care workflows, particularly in identifying patients at risk of fatal respiratory or cardiac arrest outside of the ICU.
AvoMD specializes in converting PDF guidelines and static decision-tree protocols into practical digital tools seamlessly integrated into clinical workflows through electronic health record (EHR) integration and mobile apps.
For instance, when a nurse on the rapid response team encounters a patient with an abnormal heart rate (tachycardia), AvoMD promptly processes the patient’s vital signs and recommends the most suitable next steps based on hospital-specific protocols.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Alternatively, nurses seeking immediate access to the latest evidence on tachycardia in patients with specific comorbidities can swiftly retrieve patient-specific guidance through the AvoMD mobile app within seconds.
AvoMD’s enterprise solution ensures strict governance, with health system “builders” or super admins having access to customize the platform to suit their needs.
End users interact with the Avo Point of Care App or Avo tab within their EHR, seamlessly integrating into their workflow as a clinician-facing tool.
Other health systems can leverage the tools developed by Mass General Brigham on AvoMD, either as-is or customized according to their requirements.
Joongheum Park, AvoMD’s co-founder and Head of Product and Engineering, explained that the company also incorporates actions into pathways, aiming to alleviate clinician burnout by offering a comprehensive, HIPAA-secure workflow solution within the EHR, automating tasks throughout the clinical journey.
The impact of this collaboration will be evaluated by the Healthcare Transformation Lab at Massachusetts General Hospital, utilizing both quantitative and qualitative measures, including analytics and user surveys, to gather data.
Insights derived from this data will inform further refinement of clinical pathways, enhance user experience, and determine the timing and scope for broader deployment of AvoMD.
In the larger context, AvoMD secured a $5 million seed funding round led by AlleyCorp last year, underscoring the growing trend of AI-enabled solutions in healthcare. Such technologies hold promise in providing care teams and physicians with expedited access to patient information, streamlining workflows, and ultimately improving care quality. Other platforms like Reveleer’s AI focus on risk adjustment, quality improvement, and revenue optimization through integrated patient data and workflow solutions.